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Background: Calcyon has been associated with various dopamine D1 receptor signalings despite no direct interaction
between them.
Results: Calcyon forms a novel ternary complex with D1DR through PSD-95.
Conclusion: Calcyon, by forming a ternary complex, regulates D1DR internalization in a phosphorylation-dependent manner.
Significance: Regulation of dopaminergic signaling by calcyonPSD-95D1DR complex may represent a novel target for related
neuropsychiatric disorders.
Calcyon, once known for interacting directly with the dop-
amine D1 receptor (D1DR), is implicated in various neuropsy-
chiatric disorders including schizophrenia, bipolar disorder,
and attention deficit hyperactivity disorder. Although its direct
interaction with D1DR has been shown to be misinterpreted, it
still plays important roles in D1DR signaling. Here, we found
that calcyon interactswith thePSD-95 and subsequently forms a
ternary complex with D1DR through PSD-95. Calcyon is phos-
phorylated on Ser-169 by the PKC activator phorbol 12-myris-
tate 13-acetate or by the D1DR agonist SKF-81297, and its
phosphorylation increases its association with PSD-95 and
recruitment to the cell surface. Interestingly, the internalization
of D1DR at the cell surface was enhanced by phorbol 12-myris-
tate 13-acetate and SKF-81297 in the presence of calcyon, but
not in the presence of its S169A phospho-deficientmutant, sug-
gesting that the phosphorylation of calcyon and the internaliza-
tion of the surface D1DR are tightly correlated. Our results sug-
gest that calcyon regulates D1DR trafficking by forming a
ternary complex with D1DR through PSD-95 and thus possibly
linking glutamatergic and dopamine receptor signalings. This
also raises the possibility that a novel ternary complex could
represent a potential therapeutic target for the modulation of
related neuropsychiatric disorders.
As a brain-specific protein, calcyon is mainly localized in the
intracellular endosomal vesicles of dendritic spines in D1DR3-
expressing pyramidal cells in the prefrontal cortex and hip-
pocampus and dorsal striatum region (1, 2). Initially, calcyon
had been reported as a D1DR-interacting protein (DRIP), but
later studies revealed that there was no direct interaction
between calcyon and D1DR (3). Recent studies, however, have
introduced calcyon as a candidate gene for D1DR-related neu-
rophysiological disorders. Calcyon levels were elevated in
schizophrenia patients (4, 5), whereas calcyon transgenic mice
showed reduced anxiety and an impaired working memory (6,
7). Calcyon was up-regulated in the rodent model of attention
deficit hyperactivity disorder (8), and its gene variations are
known to be associated with cocaine dependence (9). In addi-
tion, calcyon is known to potentiate cross-talk between Gs-
linked D1DR and heterologous Gq/11-coupled receptors. When
primed with agonists to Gq/11-coupled receptors, calcyon
induces D1DR to stimulate intracellular Ca2 release (2, 10).
Therefore, all of the above results suggest a possible functional
interaction between calcyon and D1DR despite no direct inter-
action between them. Indeed, a recent study suggested that
calcyon-containing vesicles might transport D1DR by associat-
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ing calcyon with D1DR through their assembly to clathrin (11).
However, as a single transmembrane protein, it is not clear how
calcyon can regulate the internalization of D1DR from the
plasma membrane to endocytic vesicles.
PSD-95 is prominently expressed in postsynaptic densities
(PSDs) and is a prototypical scaffolding protein with multiple
protein interaction domains: NH2-terminus, Discs large/zona
occludens-1 (PDZ), SH3 (Src homology 3), and guanylate
kinase-like domains (12). It forms the backbone of the postsyn-
aptic protein complex that organizes receptors and signal
transduction molecules, enabling the functional effects of the
receptors at PSDs. PSD-95 is known to regulate D1DR signaling
and the formation of the D1DR-associated proteinprotein
complex (13, 14). The NH2 terminus of PSD-95 interacts with
the carboxyl-terminal tail of D1DR and facilitates constitutive
D1DR internalization as well as internalization of the NMDA
receptor, which complexes with D1DR, thus linking dopamine
signaling and glutamatergic signaling (15).
Here, we show that calcyon interacts with PSD-95. This
interaction formed a ternary protein complex containing
calcyonPSD-95 andD1DR in the dendritic spines of hippocam-
pal neurons. Furthermore, we found that calcyon was phos-
phorylated on the Ser-169 residue through a PKC-dependent
pathway. Phosphorylation of calcyon strongly enhanced its
interaction with PSD-95, increased its surface localization, and
consequently induced the internalization of the surface D1DR.
EXPERIMENTAL PROCEDURES
Constructs—To construct expression vectors for calcyon, rat
full-length calcyon cDNA (accession number: AF303658) was
extracted by PCR from rat brain cDNA library and inserted into
target vectors (EGFP-C1, pCDNA3-HA, and C-terminal
FLAG-tagged pFLAG-CMV (Sigma). Serine phosphorylation
site of calcyon (S169A) was generated by site-directed point
mutations using the QuikChange site-directed mutagenesis
kit (Stratagene. Austin, TX). Full-length rat PSD-95 (accession
number: P31016) was amplified by PCR and subcloned
into pCDNA3-HA and EGFP-N1 vectors (Invitrogen). The
HA-D1DRwas kindly provided by Dr.Wei-Dong Yao (Harvard
University), and all DNA constructs were verified by DNA
sequencing. These expression vectors were transfected into
HEK293T, SH-SY5Y cells, and neurons for Western blot and
imaging analysis.
Coimmunoprecipitation and Immunoblotting—To verify the
interaction of calcyon with PSD-95, adult rat brain was homog-
enized with a modified RIPA buffer (50 mM Tris-HCl pH 7.5, 5
mM EDTA, 150 mM NaCl, 1% Nonidet P-40, 1 mM sodium
orthovanadate, 1 mM PMSF, 10 mM leupeptin, 1.5 mM pepsta-
tin, and 1 mM aprotinin) (16) and incubated with anti-calcyon
antibody for immunoprecipitation (Santa Cruz Biotechnology,
Santa Cruz, CA) and for immunoblotting (Abcam, Cambridge,
MA). Mouse anti-PSD-95 monoclonal antibody and rabbit
anti-PSD-95 polyclonal antibody were fromNeuroMab (Davis,
CA) and Synaptic Systems (Göttingen, Germany), respectively.
HEK293T cells were cotransfected with FLAG-calcyon, PSD-
95-EGFP, and HA-D1DR, and the cells were washed twice with
cold PBS and extracted at 4 °Cwith amodifiedRIPAbuffer. The
mixtures were then incubated with 30 l of protein A-Sephar-
ose (50% slurry) for 1 h, pelleted by centrifugation, and analyzed
by SDS-PAGE (8–15% gels). Proteins on gels were transferred
to PVDF membranes (Pall Life Sciences, Ann Arbor, MI), and
the membranes were incubated with anti-calcyon (1:800), anti-
D1DR (1:1,000), or anti-PSD-95 (1:2,000) primary antibodies
for 1 h at room temperature or overnight at 4 °C. Immunoblot
was performedwith anti-HA antibody (1:1000; Covance, Princ-
eton, NJ), anti-FLAG (1:1,000; Sigma), or anti-GFP (1:3,000;
GeneTex, Irvine, CA). The immunoreactions were detected
with SuperSignal West Pico chemiluminescent substrate
(Thermo Scientific). After chemiluminescence detection using
an ImageQuant LAS 4000 (GE Healthcare, Uppsala, Sweden),
images were analyzed using the ImageJ software.
To identify the endogenous ternary complex of calcyonPSD-
95D1DR, cultured hippocampal neuron lysates (days in vitro
16) were prepared after treatment of SKF-81297 (10 M) for 15
min and harvested with modified RIPA buffer. They were then
clarified by centrifugation at 15,000  g for 30 min. Protein
concentrations were measured using a BCA assay (Pierce).
The 800–1500 g of lysates were incubated with 20 l of
protein A-Sepharose 4 Fast Flow (GEHealthcare) for 1 h at 4 °C
to remove nonspecific proteins and reincubated with anti-cal-
cyon, anti-PSD-95 (Synaptic Systems), or anti-D1DR (Santa
Cruz Biotechnology) antibodies overnight at 4 °C. To test the
roles of phosphorylation of calcyon, EGFP-calcyon transfected
HEK293T cells and FLAG-calcyonPSD-95-EGFPHA-D1DR
cotransfected HEK293T cells were incubated with 1 M PMA
(Sigma) and 10 M SKF-81297 (Santa Cruz Biotechnology),
respectively. Cell lysates were incubated with anti-GFP (Gene-
Tex) or anti-FLAG (Sigma) antibody and immunoblotted with
anti-phospho-serine antibody (Acris Antibodies GmbH, Her-
ford, Germany).
GST Pulldown Assays—Full-length rat PSD-95 (1–724), N
terminus (1–64 amino acids), PDZ1–3 (65–393 amino acids),
PDZ1 (65–151 amino acids), PDZ2 (160–246 amino acids),
PDZ3 (313–393 amino acids),SH3 (lacking amino acids 428–
498), and SH3 (428–498 amino acids) of PSD-95, full-length rat
calcyon (1–226 amino acids), extracellular region (1–88 amino
acids), C terminus (109–226 amino acids), and the 175–226-
amino acid part of the C terminus (C-End) of calcyon were
amplified by PCR and subcloned into pGEX4T-1 for the GST
pulldown assays. PCR products of calcyon (175–200 and 201–
226) were subcloned into pDESTc15 vector (Invitrogen) using
the Gateway cloning system (Invitrogen). The plasmids were
transformed into BL-21, and the transformants were cultured
in 2 YT medium supplemented with ampicillin. After a 5-h
induction with 0.5 mM isopropyl 1-thio--D-galactopyranoside
at 30 °C, the cultures were sonicated in lysis buffer (1% Triton
X-100, 0.5% sodium deoxycholate, 20 mM Tris, pH 8.0, 150 mM
NaCl, 1 mM MgCl2, 1 mM EGTA, 0.1 mM PMSF) and centri-
fuged at 15,000  g for 15 min, and the supernatants were
incubated with glutathione-agarose-4B beads (GE Health-
care) for 1 h at 4 °C. After washing three times with lysis
buffer, the beads were incubated for 2 h at 4 °C or overnight
with brain lysates in lysis buffer. The beads were then washed
extensively with lysis buffer and analyzed by SDS-PAGE and
immunoblotting.
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In Vitro Phosphorylation Assay—The 156–206-a.a domains
of calcyon (P-WT) and S169A mutant (P-SA) were cloned into
pDEST15 vector using the Gateway cloning system and trans-
formed to BL-21. The Escherichia coli was sonicated with lysis
buffer (1% Triton X-100, 0.5% sodium deoxycholate, 20 mM
Tris, 150 MmNaCl, 1 mMMgCl2, 1 mM EGTA, PH 7.2, 0.1 mM
PMSF). The phosphorylation of wild type (P-WT) and phos-
pho-mutant S169A (P-SA) was performed using glutathione-
Sepharose 4B resin (GEHealthcare). For the in vitro phosphor-
ylation assay, 25g of purifiedGST-P-WTandGST-P-SAwere
incubated with 20 ng of PKC-catalytic subunit (Millipore, Bil-
lerica, MA) in PKC assay dilution buffer II with 2 mM Mg2-
ATP containing phosphatase inhibitor mixture III (Sigma) at
30 °C for 40 min. The reaction was stopped by adding 10 mM
EDTA and centrifuged at 1000 g for 1 min, and the superna-
tant was removed. 2 SDS-Laemmli buffer was added without
washing followed by SDS-PAGE. P-WT phosphorylation was
detected by immunoblotting with phospho-serine antibody
(Acris Antibodies GmbH).
cAMP Enzyme Immunoassay—HEK293T cells were tran-
siently transfected with FLAG-calcyon, PSD-95-EGFP, and
HA-D1DR using Lipofectamine 2000 (Invitrogen) and grown
for 27 h in complete DMEM medium and then serum-starved
for 16 h before SKF-81297 treatment. The cells were stimulated
by 10 M SKF-81297 for 30 min, and cAMP accumulation was
measured with a cAMP direct immunoassay kit (Abcam). In
brief, DMEM was removed from the plate, and cells were
washed with warmed 1Dulbecco’s PBS briefly and incubated
with 0.1 M HCl at room temperature for 20 min. Cells were
dissociated by pipetting up and down, neutralizing buffer and
acetylation reagent mixture were added to the cell lysates (1
g/l concentration), and reaction mixtures were incubated at
room temperature for 10 min. Each acetylated sample and
standards were transferred to a protein G-coated white 96-well
plate. Rabbit anti-cAMP polyclonal antibody was added to
standard, and samples and reaction mixtures were incubated
for 1 h at room temperature, reincubated with cAMP-HRP for
1 h, washed, and developedwith theHRP developer for 1 h. The
reactionwas stopped by adding 1 MHCl and read the plate at an
optical density of 450 nm.
Cell Culture, Immunocytochemistry, and Image Acquisition—
HEK293T and SH-SY5Y cells were cultured at 37 °C and 5%
CO2 in Dulbecco’s modified Eagle’s medium (Invitrogen) sup-
plemented with 10% fetal bovine serum (HyClone, Logan, UT).
Transfection was carried out using Lipofectamine 2000 (Invit-
rogen), and cells were observed after 24–36 h. The confocal
images were acquired with an Olympus FV 1000 using a
sequential scan tool mounted on an Olympus IX-81 micro-
scope fitted with a 100/1.4 NA objective lens driven byOlym-
pus FluoView software. For immunocytochemistry, cells were
fixed in 4% formaldehyde with 4% sucrose in PBS for 15 min,
permeabilized for 5 min in 0.25% Triton X-100, PBS, and
blocked for 30 min in 10% BSA, PBS at 37 °C. The cells were
incubated with primary antibodies in 3% BSA, PBS for 2 h at
37 °C or overnight at 4 °C, washed in PBS, and incubated with
secondary antibodies in 3% BSA, PBS for 45 min at 37 °C. For
colocalization experiments with calcyon, PSD-95 and D1DR,
primary cultured neurons were permeabilized with 0.25% Tri-
ton X-100 for 5 min at room temperature before primary anti-
bodies. Analysis and quantification of data were performed
withMetaMorph software (Molecular Devices, Sunnyvale, CA)
and SigmaPlot 8.0 (Systat Software, Point Richmond, CA), and
data are presented as means S.E.
Neuron Culture and Transfection—Experiments were per-
formed in accordance with guidelines set forth by the Seoul
National University Council Directive for the proper care and
use of laboratory animals. Hippocampal neurons derived from
E-18 primary rats were prepared as described (17). Briefly, hip-
pocampiwere dissected, dissociatedwith papain, and triturated
with a polished half-bore Pasteur pipette. The cells (2.5 105)
in minimum Eagle’s medium supplemented with 0.6% glucose,
1 mM pyruvate, 2 mM L-glutamine, 10% fetal bovine serum, and
antibiotics were plated on poly-D-lysine-coated glass coverslips
in a 60-mmPetri dish. Four hours after plating, themediumwas
replaced with basal media Eagle’s (Invitrogen) supplemented
with 2% B-27, 10 mM HEPES, and 0.5 mM pyruvate or Neuro-
basalmedium (Invitrogen) supplementedwith 2%B-27, 0.5mM
L-glutamine. 4 M 1--D-cytosine-arabinofuranoside (Ara-C,
Sigma) was added as needed. Neurons were transfected using
the calcium phosphate method (18).
Bimolecular Fluorescence Complementation (BiFC) Assays—
ForBiFCassays, the full-length cDNAs corresponding to the rat
calcyon, C-terminal end (175–200 a.a, 201–226 a.a) of calcyon,
and rat PSD-95 were cloned into pDONR207 vectors using
the Gateway cloning system (Invitrogen). Next, using LR Clon-
ase (Invitrogen), these entry clones were converted
into pDS_XB-VN and pDS_VN-XB or pDS_VC-XB and
pDS_XB-VC destination vectors. After sequence verification,
SH-SY5Y cells were transfected with various BiFC pairs (1:1
ratio) using Lipofectamine 2000 (Invitrogen). Cells were fixed
12–16 h after transfection with 4% paraformaldehyde and
imaged using a confocal microscope (FV-1000, Olympus).
Surface Biotinylation—After 36 h of transfection, biotinyla-
tion of cell surface proteinswas performedusing the cell surface
protein isolation kit (Thermo scientific) according to the man-
ufacturer’s instructions. Briefly, HEK293 cells grown on
100-mm plates were washed once with ice-cold PBS and incu-
bated with 0.25 mg/ml EZ-Link Sulfo-NHS-SS-Biotin in PBS
for 30 min at 4 °C. The cells were rinsed in quenching solution
with Tris-buffered saline to remove free biotin reagents and
lysed in lysis buffer. After centrifugation, supernatants were
incubated with 50l of 50% slurry of immobilizedNeutrAvidin
for 3 h at 4 °C. Reaction complexes were washed three times
with wash buffer, and then biotinylated proteins were eluted by
incubating at 37 °C for 15min in SDS sample buffer followed by
immunoblotting with an anti-HA antibody (1:1000) to detect
D1DR and anti-calcyon (1:1,000) antibodies.
RESULTS ANDDISCUSSION
A previous study showed that calcyon localizes to the den-
dritic spines of D1 receptor-expressing pyramidal cells in the
prefrontal cortex (2). PSD-95 is a prominent scaffolding protein
with multiple protein interaction domains in the dendritic
spine (19, 20). Because the subcellular fractionation data in this
study showed that calcyon and PSD-95 protein existed in the
PSD and had similar expression patterns during the develop-
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ment of rat hippocampal neurons (supplemental Fig. 1), we
wondered whether calcyon interacts with PSD-95.
To test this possibility, an immunoprecipitation analysis was
performed with adult rat whole brain lysates. Fig. 1 shows that
calcyon and PSD-95 coprecipitated, suggesting that they inter-
act with each other endogenously (Fig. 1A). When HEK293T
cells were cotransfected with FLAG-calcyon, EGFP-C1 empty
vector, clathrin light chain (Lca)-EGFP, and PSD-95-EGFP, cal-
cyon coprecipitated with Lca (lane 2) and PSD-95 (lane 3) but
not with the EGFP empty vector (Fig. 1B). This interaction was
further confirmed by BiFC assay using the improved yellow
fluorescence protein, Venus, which allows for direct visualiza-
tion of protein interactions at the subcellular sites of their inter-
actions in living cells (21–23). Fluorescence complementation
was only observed in a group of cells that coexpressed frag-
ments of Venus (VN173 or VC155) conjugated to the C termi-
nus of calcyon and to the N terminus of PSD-95 (Fig. 1C). No
complementation was detected when fragments of Venus
(VN173 or VC155) were fused to the N terminus of calcyon or
the C terminus of PSD-95 (supplemental Fig. 2A).
We further investigated which domain of PSD-95 binds to
calcyon. A series of GSTpulldown assays was donewith various
domain mutants of PSD-95 and calcyon (Fig. 2, A and B). Cal-
cyon was found to interact with the full-length PSD-95, the
PDZ1–3 domain, and the PDZ1 domain, but not with the
N-terminal region, PDZ2, PDZ3, or SH3 domain (Fig. 2C). In
addition, the full-length PSD-95 and PDZ1 domain of PSD-95
interacted with the C terminus (a.a. 109–226) and C-terminal
end (a.a. 175–226) of calcyon, but not with the extracellular
region or GST only (Fig. 2D). These results suggest that the
PDZ1 domain of PSD-95 is responsible for its binding to the
C-terminal regions (a.a. 175–226) of calcyon. Although we did
not find any consensus binding motif for the class I PDZ
domain (X(S/T)X(V/L/I)-COOH) in the C-terminal regions of
calcyon, using the PDZ domain-ligand interaction network
(PDZNet) and position weight matrices, which contain the
experimental data of the PDZ domain-ligand interaction of
human PDZ domains (21), we could identify the three putative
PDZ binding motifs in the C-terminal regions of calcyon (sup-
plemental Fig. 2C).We thus divided theC-terminal regions (a.a.
175–226) into two regions (a.a. 175–200 and a.a. 201–226,
respectively) that contained the putative PDZ binding motif(s)
and performed a GST pulldown assay. We found that a.a. 201–
226 of calcyon strongly bound to PSD-95, whereas a.a. 175–200
did not. Thiswas further supported by theBiFC results inwhich
a group of cells that coexpressed fragments of PSD-95-VN173
or VN173-PSD-95 with the calcyon-VC155 (a.a. 201–226) only
showed fluorescent complementation (Fig. 2E and supplemen-
tal Fig. 2B). Because both C-terminal fragments contain the
AXXV motif, these results indicate that AXXV motif does not
seem to be involved in PSD-95 binding. To test whether the last
four-amino acid sequence (QSPK) of calcyon is the PSD-95
binding motif, we introduced S224A point mutation in the Ser
residue of the sequence because Ser/Thr at the 2 position is
FIGURE 1.CalcyonassociateswithPSD-95.A, adult rat brain extractswere immunoprecipitated (IP) withmousemonoclonal anti-PSD-95 antibody (left panel)
or rabbit polyclonal anti-calcyon (Cal) antibody (right panel) followed by immunoblot (IB) analysis with rabbit polyclonal anti-calcyon (left panel) or mouse
monoclonal anti-PSD-95 antibody (right panel). Arrows indicate the size of calcyon (left panel) and PSD-95 (right panel) NS; nonspecific band. HC; heavy chain.
Sup; immunoprecipitated supernatants. B, HEK293T cells were cotransfected with FLAG-calcyon and EGFP-C1, PSD-95-EGFP, and Lca-EGFP. Cell lysates were
immunoprecipitatedwith anti-FLAG antibody followed by immunoblottingwith anti-GFP antibody. Lower panel: the expression of each proteinwas detected
by anti-GFP or anti-FLAG antibody. C, schematic figures showing the successful combination of BiFC between calcyon and PSD-95. Lower panels: SH-SY5Y cells
were cotransfected with various combinations of BiFC pairs. Note that except for the calcyon-VC155VN173-PSD-95 pair and calcyon-VN173VC155-PSD-95
pair, all other combinations failed to exhibit a positive fluorescence complementation. 5-HT6R/VN: 5-HT6 receptor conjugated to VN173. Cal/VC(175–200):
calcyon C terminus region (a.a. 175–200) conjugated to VC155. Scale bar 20 m; 10 m in inset.
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themost conserved residue among various PDZ bindingmotifs
(21). We found that the S224A mutant failed to bind PSD-95,
whereas the wild type strongly binds to PSD-95 (Fig. 2F).
Interaction of calcyonwith PSD-95was further confirmed by
immunocytochemistry. Neurons were doubly stained with cal-
cyon and PSD-95 antibodies. Although calcyonwas found to be
present throughout the cytosol, it partially colocalized with
PSD-95 in the dendritic spines (supplemental Fig. 3A). When
exogenously expressed, calcyon also was found in the punctate
structures, whichwere partially colocalizedwith the endosomal
marker, EEA1, in the dendritic spines (supplemental Fig. 3B).
Consistent with endogenous staining, exogenously expressed
calcyon also exhibited partial colocalization with PSD-95 (sup-
plemental Fig. 3E). We also found that calcyon was partially
colocalized with various early endosome markers; early endo-
some antigen 1 protein (EEA1), double FYVE domain from the
hepatocyte-growth-factor-regulated tyrosine kinase substrate
(2XFYVE-Hrs) or transferrin-conjugated Texas Red in COS-7
cells (supplemental Fig. 4).
The N terminus of PSD-95 is known to interact with the C
terminus of D1DR (13). Although a direct interaction between
calcyon andD1DR turned out to bemisinterpreted because our
results indicated that calcyon and PSD-95 associate with each
other, there is a possibility that calcyon andD1DR interact indi-
rectly through PSD-95 as amediator. To test this possibility, we
first incubated purified GST-calcyon or GST-only with
HEK293T cell lysates that expressed HA-D1DR and PSD-95-
EGFP and immunoprecipitated with GST antibody followed by
FIGURE 2. Calcyon interacts with PSD-95. A, schematic figures showing PSD-95 domain structures and each GST-fused domain of PSD-95. GK, guanylate
kinase-like domain. B, schematics of calcyon domain and full-length calcyon (Cal) and extracellular region (Extra), C terminus (C-term), and the 175–226-amino
acid part of the C terminus (End) of calcyon. C, brain lysates were pulled down with GST fusions of PSD-95 full length; N terminus (NT); PDZ1–3 domain; PDZ1
domain; PDZ2 domain; PDZ3 domain; SH3 domain lacking amino acids 428–498 (SH3); and SH3 domain and GST alone (DSH3). The pulldown complex was
resolved by SDS-PAGE, and immunoblotting was performed with anti-calcyon antibody (upper panel). Calcyon was identified in the full-length GST-PSD-95,
GST-PDZ1–3, GST-PDZ1, and GST-SH3 lanes. The expression of GST fusion proteins was identified using Coomassie Blue staining (lower panel). Arrowheads
indicate the purified GST-full-length PSD-95 and PDZ1–3. D, adult rat brain lysates were pulled down with GST-fused calcyon, GST-Extra (a.a. 1–226), GST-C-
term (a.a. 109–226 of the C terminus), or GST-End (a.a. 175–226), and immunoblotting was performed with anti-PSD-95 antibody (upper panel). GST fusion
proteins were identified using Coomassie Blue staining (lower panel). Arrowhead indicates GST-calcyon, and asterisks indicate GST fusion proteins. E, GST-End
of calcyon was divided into two domains (a.a. 175–200 and a.a. 201–226) in which each domain contains one putative PDZ binding motif (See supplemental
Fig. 2C). Brain lysates were pulled down with each GST fusion protein and immunoblotted with anti-PSD-95 antibody. Note that strong immunoreactivity of
PSD-95 was identified in the 201–226 lane only. Purified GST fusion proteins were identified using Coomassie Blue staining (right panel). F, brain lysates were
pulled down with GST-wild type (QSPK) or GST-S224A point mutant (QAPK). Note that S224A mutant failed to bind PSD-95, whereas the wild type strongly
binds to PSD-95. Purified GST fusion proteins were identified using Coomassie Blue staining (right panel). T, transmembrane region.
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immunoblotting with HA-antibody. We found that HA-D1DR
was coimmunoprecipitated with GST-calcyon (Fig. 3A). Sec-
ond, HEK293T cells were transfected with various combina-
tions of HA-D1DR, PSD-95-GFP, and FLAG-calcyon, and
coimmunoprecipitation followed by immunoblotting with spe-
cific antibodies was carried out. PSD-95-GFP was coprecipi-
tated with either FLAG-calcyon or HA-D1DR when doubly
transfected. Interestingly, HA-D1DR and FLAG-calcyon only
coprecipitated if PSD-95-GFP was triply cotransfected,
strongly suggesting that PSD-95 acts as a linker between cal-
cyon and D1DR (Fig. 3B). Finally, we confirmed that a
calcyonPSD-95D1DR ternary complex exists endogenously in
the brain by immunoprecipitation assay in cultured neurons
after treatment with a D1DR-specific agonist, SKF-81297 for 15
min. Immunoblot analysis with antibodies against each protein
showed that calcyon, PSD-95, and D1DR coprecipitated
together (Fig. 3C). Immunocytochemistry also showed that the
three proteins are colocalized in the dendritic spines, especially
the spine heads (Fig. 3D and supplemental Fig. 5).
The D1-like receptors activate cyclic AMP production
and bidirectionally modulate protein kinase A (PKA) and
DARPP-32 through Gs/olf (24). Intriguingly, D1DR-stimulated
Ca2 release was significantly attenuated by treatment with a
PKC inhibitor in calcyon-expressing cells, and calcyon was
found to be phosphorylated by purified PKC, although no
detailed analysis has been done (2). We also found that calcyon
was phosphorylated on the serine residue by the PKC activator
PMA, and this phosphorylation was blocked by the PKC inhib-
itors GF109203X and rottlerin but not by the PKA inhibitor
H-89 (Fig. 4A). We further investigated the specific phospho-
rylation sites of calcyon by PKC. Human calcyon is phosphory-
lated on Ser-154 and Ser-196 by PKA (2), whereas the rat cal-
cyon has a putative PKC phosphorylation site on Ser-169 in the
cytoplasmic domain (the NetPhosK 1.0 Server). HEK293T cells
were transfected with an EGFP-tagged wild-type calcyon or
S169A phospho-deficient mutant and incubated with PMA.
Fig. 4B shows that the wild type, but not the S169Amutant, was
rapidly phosphorylated on the serine residues by PMA, suggest-
FIGURE 3. Calcyon interacts indirectly with D1DR via PSD-95. A, HEK293T cells were cotransfected with EGFP-tagged PSD-95 and HA-tagged D1DR, lysed,
immunoprecipitated (IP) with GST or GST-calcyon (GST-Cal), and immunoblottedwith anti-HA antibody. Arrowhead indicates HA-taggedD1DR (left panel) and
purified GST-calcyon wild type (right panel). Purified GST-calcyon was identified using Coomassie Blue staining (right panel). B, HEK293T cells were cotrans-
fected with EGFP-tagged PSD-95, HA-tagged D1DR, and FLAG-tagged calcyon. Cells were lysed, immunoprecipitated, and immunoblotted (IB) with various
combinations of the indicated antibodies. Note that when only three proteins were cotransfected, calcyon was coimmunoprecipitated with D1DR (left panel).
Right panel), model depicting a putative molecular interaction of calcyonPSD-95D1DR. C, endogenous complex of calcyonPSD-95D1DR in the cultured
neurons. The cultured primary hippocampal neurons (days in vitro 21) were incubated with 10M SKF-81297 for 15min, lysed in RIPA buffer, immunoprecipi-
tated, and immunoblotted with rabbit polyclonal anti-D1DR, -calcyon, or -PSD-95 antibody. 10% neuron lysates (70 g) were loaded as the positive control.
D, D1DR, PSD-95, and calcyon were colocalized in the dendritic spines and dendritic shaft. Because the antibody species matter, GFP-tagged calcyon was
transfected, whereas PSD-95 and D1DR were detected endogenously with mouse anti-PSD-95 antibody (secondary antibody Alexa Fluor 405-conjugated
anti-mouse antibody) and rabbit anti-D1DR antibody (secondary antibody Alexa Fluor 594-conjugated anti-rabbit antibody).Arrows indicate the spineswhere
the calcyonPSD-95D1DR complex was colocalized. Scale bar 50 m; scale bar 10 m in inset.
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ing that Ser-169 is themajor phosphorylation site of calcyon by
PKC. This was further confirmed by an in vitro phosphoryla-
tion assay (Fig. 4C). We purified a.a 156–187 from wild type
(P-WT) and the phospho-deficient mutant S169A (P-SA) of
calcyon and incubated them with the purified PKC catalytic
subunit in the presence of ATP. Phosphorylation on the serine
residues was observed in the P-WT but not in the P-SA, sug-
gesting that calcyon is directly phosphorylated by PKC on Ser
169 (Fig. 4C).
We next tested whether the phosphorylation of calcyon
modulates its interaction with PSD-95. HEK293T cells were
transfected with FLAG-calcyon and incubated with 1 M PMA
for 10 min. Then, the lysates were precipitated with purified
GST-PSD-95 beads and immunoblotted with FLAG-antibod-
ies. Fig. 4D shows that the interaction between calcyon and
PSD-95 was dramatically increased by treatment with PMA.
Interestingly, calcyon was also phosphorylated on the serine
residues after SKF-81297 treatment, whereas the S169A
mutant was not (Fig. 4E). Direct activation of PKC by PMA
resulted in a maximum increase of calcyon phosphorylation
only 5 min after treatment (Fig. 4B), whereas SKF-81279 treat-
ment induced maximum calcyon phosphorylation 15 min after
FIGURE 4. Phosphorylation of calcyon by PKC enhances its interaction with PSD-95. A, the phosphorylation of calcyon by PKC. HEK293T cells were
transfectedwith EGFP-calcyon and preincubatedwith DMSO and 20MH-89 (PKA inhibitor) for 20min or two different PKC inhibitors, 5MGF109203X (GFX)
for 45 min and 30 M rottlerin (Rot) for 30 min. After preincubation, cells were treated with 1 M PMA, a PKC activator, for 10 min, harvested, and coimmuno-
precipitated with anti-GFP antibody followed by immunoblotting with anti-phospho-serine antibody. Lower bar graphs: quantification from three indepen-
dent experiments. Data are the mean S.E. Asterisks indicate a significant change when compared with the group(s) indicated (one-way ANOVA; *, p 0.05,
**, p 0.01). CTL, control. B, HEK293T cells expressing EGFP-calcyon (EGFP-Cal) or phospho-deficient mutant EGFP-calcyon (S169A) (EGFP-Cal (S169A)) were
incubated with PMA for the indicated times and coimmunoprecipitated with anti-GFP antibody followed by immunoblotting with phospho-serine (P-Ser)
antibody. C, purified GST-taggedwild type (P-WT) and phospho-deficientmutant S169A (P-SA) of calcyonwere incubatedwith the PKC catalytic subunit in the
presenceofATP. Thephosphorylationwas analyzedbySDS-PAGEand immunoblottingwithphospho-serine antibody (left panel).Arrowheads indicate thePKC
catalytic subunit and phosphorylated serine. Purified GST fusion proteins were identified using Coomassie Blue staining (right panel). D, HEK293T cells
expressing FLAG-calcyon were incubated with 1 M PMA for 10 min, and lysates were coprecipitated with GST-PSD-95 beads and immunoblotted with
anti-FLAG antibody. The amount of FLAG-calcyon pulled down with GST-PSD-95 increased more than 3-fold after treatment with PMA for 10 min. Statistical
analysis was performed using Student’s t test. **, p  0.01. AU, arbitrary units. E, HA-D1DRPSD-95-EGFP and FLAG-calcyon or FLAG-calcyon (S169A) were
cotransfected into HEK293T cells. After treatment with SKF-81297 for the indicated times, cells were lysed and immunoprecipitated with anti-FLAG antibody
followed by immunoblotting with phospho-serine antibody. Note that in the absence of HA-D1DR expression, SKF-81297 treatment failed to induce the
phosphorylationof calcyon. Lower graph: quantification from three independent experiments.Asterisks indicate significant changes in the secondgroupwhen
compared with the first and the third group at matching time points. ANOVA and Tukey’s HSD post hoc test; **, p  0.01. F, HA-D1DRPSD-95-EGFP and
FLAG-calcyon or FLAG-calcyon (S169A) were cotransfected into HEK293T cells. After treatment of SKF-81297 for the indicated times, cells were lysed and
immunoprecipitated with anti-GFP antibody followed by immunoblotting with anti-FLAG antibody. Phosphorylation of calcyon by SKF-81297 increased its
interaction with PSD-95. Asterisk indicates significant changes in the second group when compared with the first group at matching time points. ANOVA and
Tukey’s HSD post hoc test; *, p 0.05.
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treatment (Fig. 4E), suggesting that D1DR activation by SKF-
81297 indirectly causes PKC activation during D1DR signal
transduction. Consistently, SKF-81297 treatment significantly
increased the interaction of PSD-95 with calcyon but not with
the S169A mutant (Fig. 4F).
PSD-95 interacts with D1DR, promoting the internalization
of the surface D1DR (13). Thus, we next investigated whether
calcyon could regulate the internalization of the surface D1DR
through the ternary complexwith PSD-95.HEK293T cells were
triply cotransfected with HA-D1DR, PSD-95-EGFP, and the
FLAG-calcyon or FLAG-S169Amutant. The surface biotinyla-
tion assay showed that the surface level of D1DR rapidly
decreased after treatment with SKF-81297 in the presence of
calcyon. When compared with the D1DR only or D1DR with
PSD-95 groups, when calcyon was cotransfected with D1DR
and PSD-95, the slope of the decrease was much steeper (Fig.
5A). The phospho-deficient S169A mutant of calcyon failed to
induce D1DR internalization after treatment with SKF-81297
(Fig. 5A).
To further test whether the decrease in the surface level of
D1DR depends on the phosphorylation of calcyon, triply
cotransfected HEK293T cells were incubated with 10 M SKF-
81297, 1MPMA, or 5MGF109203X, and the surface levels of
D1DR were measured. Fig. 5B shows that both PMA and SKF-
81297 treatments induced significant decreases in the surface
level of D1DR, whereas GF109203X treatment did not. Evi-
dently, the S169A mutant did not induce any significant
changes in the surface levels of D1DR after treatment with
PMA, SKF-81297, or GF109203X (Fig. 5B). To test whether the
formation of the ternary complex has an effect on D1DR-medi-
ated signaling, HEK293T cells were transfected with various
combinations of constructs, and after incubation with 10 M
SKF-81297 for 30 min, cAMP levels were measured (Fig. 5C).
We found that in the presence of calcyon, PSD-95, and D1DR,
SKF-81297-stimulated cAMP production was significantly
reduced when compared with D1DR only or PSD-95 with
D1DR. The phospho-deficientmutant of calcyon (S169A) failed
to affect cAMP production. Because the interaction between
FIGURE 5. The phosphorylation of calcyon and the internalization of the surface D1DR are tightly correlated. A, HEK293T cells were transfected with
various combinations of constructs as indicated. Cells were then exposed to 10 M SKF-81297 for the indicated times, and surface biotinylation experiments
were performed as described under ”Experimental Procedures.“ The surface levels of D1DR were gradually decreased after SKF-81297 treatments in cells
coexpressing D1DR and PSD-95 or D1DR, PSD-95 and calcyon, although when the three proteins were coexpressed, the rate of decrease wasmuch faster. The
phospho-deficient mutant of calcyon (S169A) failed to induce D1DR internalization after treatment with SKF-81297. Lower graphs: quantification from five
independent experiments (left graph). The surface intensity values of D1DR at the indicated times were normalized to the that at time 0 to emphasize the rate
of internalization of surface D1DR after SKF-81297 treatment (right graph). Asterisks indicate significant changes in each group when compared with the HA-
D1DR group atmatching time points. ANOVA and Tukey’s HSD post hoc test; *, p 0.05, **, p 0.01. B, HEK293T cells expressing the FLAG-calcyon (FLAG-Cal)
or FLAG-calcyon (S169A) with HA-D1DRPSD-95-EGFP were incubated with 10 M SKF-81297 or 1 M PMA for 30 min in the presence or absence of 5 M
GF109203X (GFX). Surface biotinylation experiments were performed, and surface as well as total levels of D1DRs were measured by immunoblotting with
anti-HA antibody. The intensity of surface biotinylated proteins was normalized to the total protein intensity. Lower graphs: quantification from three inde-
pendent experiments. Asterisks indicate significant changes in the PMA- or SKF-81297-treated group when compared with the DMSO-treated group or
GF109203X-treated group. Data represent the mean S.E. ANOVA and Tukey’s HSD post hoc test; *, p 0.05, **, p 0.01. C, HEK293T cells were transfected
with the same constructs as in A. Cells were then exposed to 10M SKF-81297 for 30min, and cAMP direct immunoassays were performed as described under
”Experimental Procedures.“ The SKF-81297-induced cAMP accumulation levels were significantly diminished in cells coexpressing D1DR, PSD-95, and calcyon
whencomparedwithD1DRorD1DRwithPSD-95. Thedata aremeans S.E. fromat least three independent experiments.Asterisks indicate significant changes
between linked groups. ANOVA and Tukey’s HSD post hoc test; *, p 0.05.
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calcyon and PSD-95 increased by the phosphorylation of cal-
cyon, our results suggest that D1DR activation by SKF-81297
induces the PKC-mediated phosphorylation of calcyon, which
promotes the formation of a ternary complex between calcyon
andD1DR throughPSD-95 and consequently induces the inter-
nalization of D1DR, thus inhibiting D1DR signaling.
Previously, calcyon and D1DR were thought to interact with
each other, but later on, it was discovered there was no direct
interaction between them (8). Growing evidence, however,
indicates that calcyon has important roles in D1DR-mediated
signaling pathways as well as in various D1DR-related neuro-
psychiatric disorders (4, 5, 25–27). Therefore, it was widely
assumed that calcyon could interact with D1DR either func-
tionally or indirectly. D1DR is regulated by the glutamatergic
scaffolding protein PSD-95 through direct interaction, which
facilitates the constitutive internalization ofD1DR aswell as the
internalization of the NMDA receptor that complexes with
D1DR (15). In addition, D1DR interacts with NMDA receptor
and balances NMDA receptor-mediated responses through
both a PKA-dependent pathway and a Ca2-dependent mech-
anism (28). Furthermore, recent studies revealed that calcyon is
required for the NMDA activity-dependent internalization of
AMPA receptor, which leads to long-term depression (29). All
of these results imply that there could be many possible inter-
actions involving D1DR, calcyon, and glutamate receptors. In
the present study,we showed that calcyon forms a novel ternary
complex with D1DR through PSD-95, thus linking calcyon to
D1DR.
The PDZ homology domain is the most abundant protein
interacting domain, and greater than 500 PDZ domains have
been identified in eukaryotic cells so far (30). The PDZ1domain
of PSD-95 is known to interact with GluR6, the C terminus of
the NMDA receptor NR2 subunits, and the C terminus of the
Kir2.1 and Kv1.4 potassium channels (31–34). There are no
reports as to whether rat calcyon has the PDZ binding motif,
but we found that the last four-amino acid sequence (QSPK) of
calcyon mediates the interaction with the PDZ-1 domain of
PSD-95 (Fig. 2E and supplemental Fig. 2, B and C). Therefore,
calcyon may compete with other proteins for binding to PSD-
95, which subsequently affects the signaling pathways down-
stream to these proteins, although this requires further detailed
study.
Human calcyon is predicted to be phosphorylated by PKC,
although direct evidence has not been provided (2). We found
that rat calcyon contains eight putative phosphorylation sites,
but the Ser-169 residue is a unique site that can be phosphory-
lated by PKC. Indeed, the phospho-deficient mutant S169A
largely failed to be phosphorylated by the PKC activator PMA
(Fig. 4B). Interestingly, the D1DR-specific agonist SKF-81297
also increased the phosphorylation levels of wild-type calcyon
but not those of the S169A mutant, indicating that the D1DR
signaling pathwaymay activate PKCeither directly or indirectly
to phosphorylate calcyon.
PKC-mediated phosphorylation of calcyon does affect its
binding to PSD-95. As the phosphorylation level of calcyon
increases, the binding to PSD-95 increases. Because PSD-95 is
known to bind D1DR, the phosphorylation of calcyon by PKC
possibly enhances the formation of the ternary complex of
calcyonPSD-95D1DR. What is the consequence of forming
this ternary complex? We showed that phosphorylation of cal-
cyon increased the internalization of D1DR from the cell sur-
face. Thus, we could speculate about the existence a possible
feedback loop during D1DR signaling. D1DR is activated by its
agonist followed by signaling to its downstream effectors,
which activates PKC that subsequently phosphorylates calcyon.
The phosphorylated calcyon binds more strongly to PSD-95
and is recruited to the cell surface either by its binding to
PSD-95 or by other unknownmechanisms and forms a ternary
complex with PSD-95 and D1DR, which consequently induces
the internalization ofD1DR from the cell surface (supplemental
Fig. 6). Our data imply that the formation of the calcyonPSD-
95D1DR complex in dendritic spines would indirectly inhibit
D1DR-mediated signaling by “physically” reducing the surface
levels of D1DR and thus may provide a novel target for D1DR-
related neuropsychiatric diseases such as schizophrenia and
attention deficit hyperactivity disorder. Whether the phospho-
rylation-dependent formation of a ternary complex among
calcyonPSD-95D1DR directly affects D1DR-mediated signal-
ing and plays a role in linking dopaminergic and glutamatergic
signaling in the brain would be of great interest but certainly
requires further investigation.
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